CXCL1 and hyperlipidemia: Blocking the LPA receptors 1 and 3 reduced hyperlipidemia-induced arterial leukocyte arrest and atherosclerosis in the presence of functional CXCL1, indicating that hyperlipidemia-induced monocyte recruitment depends on LPA (4).